These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37857573)

  • 1. Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real-world observational study.
    Shabnam S; Abner S; Gillies CL; Davies MJ; Dex T; Khunti K; Webb DR; Zaccardi F; Seidu S
    Diabetes Obes Metab; 2024 Feb; 26(2):512-523. PubMed ID: 37857573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study.
    Folse HJ; Mukherjee J; Sheehan JJ; Ward AJ; Pelkey RL; Dinh TA; Qin L; Kim J
    Diabetes Obes Metab; 2017 Jul; 19(7):1006-1013. PubMed ID: 28211604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
    Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
    Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
    Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
    PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.
    Ampudia-Blasco FJ; Palanca A; Trillo JL; Navarro J; Real JT
    J Diabetes Complications; 2021 Mar; 35(3):107828. PubMed ID: 33436143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
    Hall GC; McMahon AD; Carroll D; Home PD
    PLoS One; 2012; 7(11):e49908. PubMed ID: 23166795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
    Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
    J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
    Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
    J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
    Satoh J; Andersen M; Bekker Hansen B; Larsen Thorsted B; Tutkunkardas D; Zacho M; Maegawa H
    PLoS One; 2018; 13(9):e0198160. PubMed ID: 30226870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
    Rajpathak SN; Rajgopalan S; Engel SS
    J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
    Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
    Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin.
    Shabnam S; Gillies CL; Davies MJ; Dex T; Melson E; Khunti K; Webb DR; Zaccardi F; Seidu S
    Diabetes Res Clin Pract; 2023 Sep; 203():110888. PubMed ID: 37604284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titratable fixed-ratio combination of basal insulin plus a glucagon-like peptide-1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes.
    Gomez-Peralta F; Al-Ozairi E; Jude EB; Li X; Rosenstock J
    Diabetes Obes Metab; 2021 Jul; 23(7):1445-1452. PubMed ID: 33651460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabet Med; 2017 Feb; 34(2):213-222. PubMed ID: 27279380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
    Tong L; Pan C; Wang H; Bertolini M; Lew E; Meneghini LF
    Diabetes Obes Metab; 2018 Apr; 20(4):831-839. PubMed ID: 29119712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
    Ji L; Bonnet F; Chen H; Cooper A; Hammar N; Leigh P; Luporini Saraiva G; Ramirez L; Medina J; Nicolucci A; Rathmann W; Shestakova MV; Surmont F; Tang F; Watada H;
    Diabetes Res Clin Pract; 2021 Aug; 178():108947. PubMed ID: 34252505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum management of type 2 diabetes--timely introduction, optimization and intensification of basal insulin.
    Dailey G
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():5-13. PubMed ID: 18577152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
    Fu AZ; Sheehan JJ
    Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.
    Khunti K; Wolden ML; Thorsted BL; Andersen M; Davies MJ
    Diabetes Care; 2013 Nov; 36(11):3411-7. PubMed ID: 23877982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensification patterns and the probability of HbA
    Pantalone KM; Misra-Hebert AD; Hobbs TM; Ji X; Kong SX; Milinovich A; Weng W; Bauman JM; Ganguly R; Burguera B; Kattan MW; Zimmerman RS
    Diabet Med; 2020 Jul; 37(7):1114-1124. PubMed ID: 30653705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.